Review began 09/24/2022 review ended 10/01/2022 published 10/04/2022 © copyright

HIGHLIGHTS

  • who: Report and colleagues from the Department, Hospital General de Mu00e9xico DrEduardo Liceaga, Mexico City, MEX have published the research: Review began 09/24/2022 Review ended 10/01/2022 Published 10/04/2022 u00a9 Copyright, in the Journal: (JOURNAL)
  • what: The authors report the case of a patient who developed perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) associated with rapidly progressive glomerulonephritis after ChAdOx1 (AstraZeneca) SARS-CoV-2 vaccination.

SUMMARY

    The coronavirus disease 2019 (COVID-19) pandemic had a devastating impact on health and quality of life globally. The introduction of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?